CRISPR knockout screening identifies combinatorial drug targets in pancreatic cancer and models cellular drug response

Journal: Nature Communications

Published: 2018-10-15

DOI: 10.1038/s41467-018-06676-2

Affiliations: 4

Authors: 16

Go to article
Institutions FC
Department of Biochemistry and Molecular Genetics (BMG), UVA, United States of America (USA) 0.63
Department of Surgery, UVA, United States of America (USA) 0.25
Department of Pathology, UVA, United States of America (USA) 0.06
Department of Microbiology, Immunology, and Cancer Biology (MIC), UVA, United States of America (USA) 0.06

Return